Senestech Inc
NASDAQ:SNES

Watchlist Manager
Senestech Inc Logo
Senestech Inc
NASDAQ:SNES
Watchlist
Price: 2.26 USD 0.89% Market Closed
Market Cap: 11.8m USD

Senestech Inc
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Senestech Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Senestech Inc
NASDAQ:SNES
Operating Income
-$5.9m
CAGR 3-Years
16%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Operating Income
$24.9B
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Operating Income
$16.1B
CAGR 3-Years
11%
CAGR 5-Years
22%
CAGR 10-Years
19%
Pfizer Inc
NYSE:PFE
Operating Income
$18.3B
CAGR 3-Years
-23%
CAGR 5-Years
12%
CAGR 10-Years
3%
Merck & Co Inc
NYSE:MRK
Operating Income
$24.5B
CAGR 3-Years
7%
CAGR 5-Years
27%
CAGR 10-Years
11%
Eli Lilly and Co
NYSE:LLY
Operating Income
$26.4B
CAGR 3-Years
46%
CAGR 5-Years
34%
CAGR 10-Years
22%
No Stocks Found

Senestech Inc
Glance View

Market Cap
11.8m USD
Industry
Pharmaceuticals

SenesTech, Inc. engages in the development and commercialization of a proprietary technology for the management of animal pest populations, primarily rat populations through fertility control. The company is headquartered in Flagstaff, Arizona and currently employs 26 full-time employees. The company went IPO on 2016-12-08. The Company’s product ContraPest, is in the pest control industry in attacking the reproductive systems of both male and female rats. ContraPest is a liquid bait containing the active ingredients four vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest has two active ingredients, including 4-VCD and triptolide. Triptolide is derived from the thunder god vine Tripterygium wilfordii, used in traditional Chinese medicines and other over-the-counter supplements. Triptolide affects the reproductive capacity of both male and female rats. VCD is an occupational chemical that selectively destroys ovarian follicles in rats. The firm also continues to research and develop enhancements to ContraPest that align with its target verticals and other potential fertility control options for additional species.

SNES Intrinsic Value
2.91 USD
Undervaluation 22%
Intrinsic Value
Price

See Also

What is Senestech Inc's Operating Income?
Operating Income
-5.9m USD

Based on the financial report for Sep 30, 2025, Senestech Inc's Operating Income amounts to -5.9m USD.

What is Senestech Inc's Operating Income growth rate?
Operating Income CAGR 5Y
8%

Over the last year, the Operating Income growth was 13%. The average annual Operating Income growth rates for Senestech Inc have been 16% over the past three years , 8% over the past five years .

Back to Top